NASDAQ:CMPS
Compass Pathways PLC Stock News
$7.84
-0.150 (-1.88%)
At Close: May 17, 2024
Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
07:00am, Friday, 10'th Sep 2021
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris, t
Time to Buy the Magic Stocks? Magic Mushrooms, That Is.
12:39pm, Wednesday, 08'th Sep 2021
The first state to legalize cannabis for medical use was California, in 1996. In 2001, medical marijuana was approved in Canada.
COMPASS Pathways to participate in Citi, Morgan Stanley and HC Wainwright investor conferences in September
10:00am, Tuesday, 07'th Sep 2021
London, UK – 7 September 2021, Sept. 07, 2021 (GLOBE NEWSWIRE) -- London, UK – 7 September 2021 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to a
3 Biotech Stocks Wall Street Expects to Double Soon
07:03am, Tuesday, 07'th Sep 2021
All three stocks on this list can more than double your money according to investment bank analysts who cover them.
Open-Minded? Buy This Game-Changing Psychedelics Stock Now
07:39am, Thursday, 26'th Aug 2021
Excellent investing opportunities frequently seem outlandish.
Are Options Traders Betting on a Big Move in COMPASS Pathways (CMPS) Stock?
09:13am, Wednesday, 18'th Aug 2021
Investors need to pay close attention to COMPASS Pathways (CMPS) stock based on the movements in the options market lately.
3 Disruptive Mental Health Stocks to Consider Buying Before They're Huge
09:34am, Saturday, 14'th Aug 2021
They're the first pioneers in exciting new markets.
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
07:00am, Wednesday, 11'th Aug 2021
LONDON, Aug. 11, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, toda
Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022
06:01pm, Wednesday, 04'th Aug 2021
By 2030, psychedelic therapy will be the gold standard for mental health treatment. And Compass is at the forefront of commercialization.
COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021
08:27am, Wednesday, 04'th Aug 2021
London, UK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,
COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences
08:00am, Tuesday, 03'rd Aug 2021
COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences
7 Stocks to Buy if You Think Alternative Therapies Are the Future
12:52pm, Monday, 02'nd Aug 2021
Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments. The post 7 Stocks to Buy if You Think Alternative Therapies Are the Fut
Is It Too Early to Invest in Psychedelic Stocks?
06:12am, Tuesday, 20'th Jul 2021
Legislation is starting to open up the industry but investors who are hoping to cash in on its growth opportunities could be waiting a very long time.
COMPASS Pathways to participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit
07:00am, Wednesday, 07'th Jul 2021
London, UK, July 07, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,
London, UK – 5 July 2021
